Low Dose Naltrexone (LDN), Dquixote1217 & HappyHealthyGirl

Hi Everyone here,

I have not been coming here in a long while but visiting and reading latest postings today, I am seeing more and more that the 'experts' on the two extremes of Alternative and traditional medication here seem to be the ones in the headline.

I sincerely believe each one is after the good of all those infected and seeking good health and are offering their best piece of advice. I however think they should be flexible on their stance of 'no scientific proof not good' and 'if its not Sutherlandia OPC herbal cancer cure it cant be good' attitude.

Although I know both have good intentions, its difficult reading the volume of material HappyHealthyGirl posts are so much so that one gets bored, is not able to read through all to get the salient points she is trying to make. Then again its a bit too academic and scientific and if it were for that I think most people would not be here on curezone. Also what about 75% of people who anti-retroviral fail? where should they turn to when all other things seem so bleak. I believe like in the scenario created by Dquixote of drowning and a chance of survival no one would have to read, dig and research to know its safe when others are seen to be moving to safety by such.

Also Dquixote1217 posts are also always saying the same thing. 100% success with Sutherlandia OPC herbal cancer cure not failing a single patient. Of course Dquixote1217 that is too promising and I feel objective readers have some doubts there. Nothing can be 100% successful for Godd sake. He says he trusts what he has seen but like HHG asks 'has he really seen'?

I posted here a while ago about how some therapies are being successful with patients in Ghana and all Dqquixote said was of course nothing can be better in Africa than Sutherlandia OPC. Hmmmmm, what have you seen? then everyone that has suggested something else on this forum has Dquixote raising some doubt and trumpeting Sutherlandia from the rooftops.

Well, I really want Sutherlandia OPC herbal cancer cure to work as its being advertised and I have some patients in my charity who cannot afford medication, can anyone help support them get drugs (they are ready to try anything and be used as 'guinea pigs') so that we post our independent results here for the benefit of all.

And HappyHealthyGirl can you help by telling us the 'special' drugs that your doctor recommended that helped you so much or something about tangible stuff rather than the long Havard University essays?

Well, I also found out about a drug (one capsule a night pill)that I would place as a mix between orthodox and alternative that could help keep people's system in place for so long before anti-retrovirals.

I am going to paste the information on this below and await arguments of pros and cons.

In Brief

Since the mid-1980's, low dose naltrexone (LDN) has consistently demonstrated a markedly beneficial effect in the treatment of HIV/AIDS. There are a score of such patients who, even today, continue to successfully use only LDN. When combined with HAART, LDN has shown itself to be an absolute preventive for lipodystrophy, as well as a synergistic therapy that diminishes viral breakthroughs and bolsters the restoration of CD4 cell levels.
Recent Developments
> Treating HIV Using LDN Alone

Dr. Bihari reports that, as of November 2001, a group of 18 such patients had an average of 9.5 years of known HIV-positive status. They had been taking LDN continuously for an average of almost 7 years, and none had participated in regular maintenance therapy with HAART. Had these patients been untreated, their CD4 counts by now should have been at quite low levels and their clinical status should have been perilous.

Instead, the most recent laboratory data for these patients shows that the vital indicators of immune status have, on average, declined only minimally during the many years. The average CD4 count within the group is 445 cells (normal = 550-1500) and the average CD4% is 28.6% (normal = 27%-53%). And, indeed, they all remain free of opportunistic infections and other indicators of AIDS.

All of these patients started with CD4 counts of greater than 300. Dr. Bihari indicates that most patients with lower CD4 counts showed a decline in CD4 number and percentage over time, though much more slowly than untreated patients used to.

Noteworthy Cases

Examples of patients with successful treatment outcomes,
as of December 2001:

(Note: patients listed started naltrexone at the 3mg dosage. Beginning November 2000, all patients switched to naltrexone 4.5mg at Dr. Bihari's suggestion.)

V., a 47-year-old man, was diagnosed HIV-positive October 1989, but did not begin taking LDN until June 1992. In April 1992 he showed a CD4 count of 580 (CD4%=29). In July 1999, after 7 years on LDN with no antiretrovirals, his CD4 count was up, at 776 (CD4%=29.4). His general health status as of an April 2000 office visit to Dr. Bihari was good.

M., a 53-year-old man, was diagnosed HIV-positive in July 1990. He started on LDN January 1991, with a baseline CD4 count of 742. More than 10 years later, his CD4 count was slightly higher, at 778. At his latest office visit to Dr. Bihari, in September 2001, he was found to have mild neuropathy and lymphocytosis. At no time has this patient taken antiretroviral medication.

L., a 37-year-old woman, was diagnosed HIV-positive in March 1992, and began taking LDN 5 months later. Prior to starting on LDN, she took AZT for an unspecified period of time. Her CD4 level, as measured in April 1992, was 321 (CD4%=50.3). Her latest test results, as of June 1999, showed a CD4 level increase to 444 (CD4% had decreased to 42.9). She had never taken antiretrovirals. In her latest office visit to Dr. Bihari (January 2001), she was pregnant and doing well. She recently gave birth to an HIV-negative baby.

S., a 40-year-old man, was diagnosed HIV-positive in 1992, and began taking LDN in December 1993, at which time his baseline CD4 count was 422 (CD4%=20). His latest lab tests, administered December 2001, after 8 years on LDN with no antiretrovirals, showed a CD4 count of 756 (CD4%=25). His general health status as of his latest visit to Dr. Bihari (December 2001) was excellent.

G., a 48-year-old man, was diagnosed HIV-positive and began taking LDN in May 1997. Measured in March of 1997, his baseline CD4 count was 557 (CD4%=33). His most recent lab test, October 2001, showed a CD4 level increase to 718 (CD4%=42). Health status was good as of a November 2001 office visit. Note: This patient began taking the antiretrovirals Crixivan and Viramune at the same time he started on LDN, but stopped taking them at Dr. Bihari's suggestion after three and a half months.

Example of patient on antiretroviral therapy having prompt response to lipodystrophy when LDN added (June 2002):

M., a 53-year-old woman, not only had diabetes, which required a moderately high dosage of insulin (90 units daily), but also was suffering from lipodystrophy as a complication of her AIDS therapy. In early May, Dr. Bihari noted that he expected LDN would combat her lipodystrophy (which includes insulin resistance) and therefore would probably decrease her insulin needs. Three weeks later, he saw her again for the first time since LDN had been started. Her insulin requirements had dropped from 90 units/day to 20 units/day during those three weeks, and her "buffalo hump" (a swelling at the upper back/lower neck area characteristic of lipodystrophy) had regressed by two-thirds. Her swollen abdomen had begun to recede, enabling her, she said, to cross her legs "for the first time in a year".

More information at:
http://www.lowdosenaltrexone.org/
Tweet